{"id":34251,"date":"2025-05-27T16:29:41","date_gmt":"2025-05-27T08:29:41","guid":{"rendered":"https:\/\/flcube.com\/?p=34251"},"modified":"2025-05-27T16:32:35","modified_gmt":"2025-05-27T08:32:35","slug":"harbin-gloria-partners-with-kowa-pharmaceuticals-to-promote-parmodia-in-china","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=34251","title":{"rendered":"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China"},"content":{"rendered":"\n<p>China-based Harbin Gloria Pharmaceuticals Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/002437:SHE\">SHE: 002437<\/a>) announced last week that it has entered into a co-promotion agreement with Kowa Pharmaceuticals (China) Co., Ltd., a subsidiary of Japan&#8217;s Kowa Company Ltd. The collaboration centers on Parmodia (pemafibrate), with Gloria Pharma taking charge of promotion activities in the designated area. In return, Kowa Pharma will provide service fees and promotional support.<\/p>\n\n\n\n<p><strong>Parmodia&#8217;s Approval and Indication<\/strong><br>Parmodia, recognized as the world\u2019s first highly selective peroxisome proliferator-activated receptor alpha (PPAR\u03b1) agonist, received approval in China in April 2025. It is indicated for the treatment of non-familial hypertriglyceridemia in adult patients to reduce triglyceride (TG) levels, in addition to dietary management.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u8a89\u8861\u836f\u4e1a\uff1a\u5173\u4e8e\u4e0e\u5174\u548c\u5236\u836f\uff08\u4e2d\u56fd\uff09\u6709\u9650\u516c\u53f8\u5c31\u4f69\u739b\u8d1d\u7279\u7247\u7b7e\u8ba2\u5171\u540c\u63a8\u5e7f\u534f\u8bae\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u8a89\u8861\u836f\u4e1a\uff1a\u5173\u4e8e\u4e0e\u5174\u548c\u5236\u836f\uff08\u4e2d\u56fd\uff09\u6709\u9650\u516c\u53f8\u5c31\u4f69\u739b\u8d1d\u7279\u7247\u7b7e\u8ba2\u5171\u540c\u63a8\u5e7f\u534f\u8bae\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-d985723d-4129-4923-8d15-a2a376c684a3\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u8a89\u8861\u836f\u4e1a\uff1a\u5173\u4e8e\u4e0e\u5174\u548c\u5236\u836f\uff08\u4e2d\u56fd\uff09\u6709\u9650\u516c\u53f8\u5c31\u4f69\u739b\u8d1d\u7279\u7247\u7b7e\u8ba2\u5171\u540c\u63a8\u5e7f\u534f\u8bae\u7684\u516c\u544a.pdf\">\u8a89\u8861\u836f\u4e1a\uff1a\u5173\u4e8e\u4e0e\u5174\u548c\u5236\u836f\uff08\u4e2d\u56fd\uff09\u6709\u9650\u516c\u53f8\u5c31\u4f69\u739b\u8d1d\u7279\u7247\u7b7e\u8ba2\u5171\u540c\u63a8\u5e7f\u534f\u8bae\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u8a89\u8861\u836f\u4e1a\uff1a\u5173\u4e8e\u4e0e\u5174\u548c\u5236\u836f\uff08\u4e2d\u56fd\uff09\u6709\u9650\u516c\u53f8\u5c31\u4f69\u739b\u8d1d\u7279\u7247\u7b7e\u8ba2\u5171\u540c\u63a8\u5e7f\u534f\u8bae\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-d985723d-4129-4923-8d15-a2a376c684a3\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) announced last week that it has entered&#8230;<\/p>\n","protected":false},"author":1,"featured_media":34253,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[69,1787,108,4101,1788],"class_list":["post-34251","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cvd","tag-gloria-pharmaceuticals","tag-high-blood-pressure","tag-kowa-pharmaceuticals","tag-she-002437"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) announced last week that it has entered into a co-promotion agreement with Kowa Pharmaceuticals (China) Co., Ltd., a subsidiary of Japan&#039;s Kowa Company Ltd. The collaboration centers on Parmodia (pemafibrate), with Gloria Pharma taking charge of promotion activities in the designated area. In return, Kowa Pharma will provide service fees and promotional support.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=34251\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=34251\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-27T08:29:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T08:32:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2715.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China\",\"datePublished\":\"2025-05-27T08:29:41+00:00\",\"dateModified\":\"2025-05-27T08:32:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251\"},\"wordCount\":125,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2715.webp\",\"keywords\":[\"CVD\",\"Gloria Pharmaceuticals\",\"High blood pressure\",\"Kowa Pharmaceuticals\",\"SHE: 002437\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34251#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=34251\",\"name\":\"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2715.webp\",\"datePublished\":\"2025-05-27T08:29:41+00:00\",\"dateModified\":\"2025-05-27T08:32:35+00:00\",\"description\":\"China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) announced last week that it has entered into a co-promotion agreement with Kowa Pharmaceuticals (China) Co., Ltd., a subsidiary of Japan's Kowa Company Ltd. The collaboration centers on Parmodia (pemafibrate), with Gloria Pharma taking charge of promotion activities in the designated area. In return, Kowa Pharma will provide service fees and promotional support.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34251\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2715.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2715.webp\",\"width\":1080,\"height\":608,\"caption\":\"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34251#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China - Insight, China&#039;s Pharmaceutical Industry","description":"China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) announced last week that it has entered into a co-promotion agreement with Kowa Pharmaceuticals (China) Co., Ltd., a subsidiary of Japan's Kowa Company Ltd. The collaboration centers on Parmodia (pemafibrate), with Gloria Pharma taking charge of promotion activities in the designated area. In return, Kowa Pharma will provide service fees and promotional support.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=34251","og_locale":"en_US","og_type":"article","og_title":"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=34251","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-27T08:29:41+00:00","article_modified_time":"2025-05-27T08:32:35+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2715.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=34251#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=34251"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China","datePublished":"2025-05-27T08:29:41+00:00","dateModified":"2025-05-27T08:32:35+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=34251"},"wordCount":125,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=34251#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2715.webp","keywords":["CVD","Gloria Pharmaceuticals","High blood pressure","Kowa Pharmaceuticals","SHE: 002437"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=34251#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=34251","url":"https:\/\/flcube.com\/?p=34251","name":"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=34251#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=34251#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2715.webp","datePublished":"2025-05-27T08:29:41+00:00","dateModified":"2025-05-27T08:32:35+00:00","description":"China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) announced last week that it has entered into a co-promotion agreement with Kowa Pharmaceuticals (China) Co., Ltd., a subsidiary of Japan's Kowa Company Ltd. The collaboration centers on Parmodia (pemafibrate), with Gloria Pharma taking charge of promotion activities in the designated area. In return, Kowa Pharma will provide service fees and promotional support.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=34251#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=34251"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=34251#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2715.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2715.webp","width":1080,"height":608,"caption":"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=34251#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2715.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34251"}],"version-history":[{"count":2,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34251\/revisions"}],"predecessor-version":[{"id":34256,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34251\/revisions\/34256"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/34253"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}